 In the majority of patients with morbid obesity , metabolic/bariatric surgery leads to relevant and sustained weight<symptom> loss<symptom> and improves obesity-related comorbidities , quality of life and functionality. Moreover , the associated reduction of risk factors for cardiovascular events and cancerous diseases has been shown to improve life expectations. Due to its excellent antidiabetic effect , the currently valid national S3 guidelines now recommend metabolic/bariatric surgery in patients who have a body mass index ( BMI) â‰¥ 30 kg/m